Measurement of photoneutron doses in and out of high-energy X-ray beam of a SATURNE-20 medical linear accelerator by ECE polycarbonate detectors

1999 ◽  
Vol 31 (1-6) ◽  
pp. 479-482 ◽  
Author(s):  
M. Sohrabi ◽  
A. Mostofizadeh
2018 ◽  
Vol 8 (3Sep) ◽  
Author(s):  
A S Talebi ◽  
M Maleki ◽  
P Hejazi ◽  
M Jadidi ◽  
R Ghorbani

BackgroundOne of the most significant Intensity Modulated Radiation Therapy treatment benefits is a high target to normal tissue dose ratio. To improve this advantage, an additional accessory such as a compensator is used to delivering doses. Compensator-based IMRT treatment is usually operated with an energy higher than 10 MV. Photoneutrons, which have high linear energy transfer and radiobiological effectiveness, are produced by colliding high-energy photon beams with linear accelerator structures, then they deliver the unwanted doses to patients and staff. Therefore, the neutron energy spectra should be determined in order to calculate and reduce the photoneutron risk.Objective: We have conducted a comprehensive and precise study on the influence of brass compensator thickness and field size on neutron contamination spectrum in an Elekta SL 75/25 medical linear accelerator with and without the flattening filter by Monte Carlo method.Materials and Methods: MCNPX MC Code version 2.6.0 was utilized to simulate the detailed geometry of Elekta SL 75/25 head components based on Linac’s manual. This code includes an important feature to simulate the photo-neutron interactions. Photoneutrons spectrum was calculated after the Linac output benchmarking based on tuning the primary electron beam.Results and Conclusion: Based on the Friedman and Wilcoxon nonparametric tests results (P<0.05), photoneutron fluence directly depends on the field size and compensator thickness. Moreover, the unflattened beam provides lower photoneutron fluence than the flattened beam. Photoneutrons fluence is not negligible in compensator-based IMRT treatment. However, in order to optimize treatment plans, this additional and unwanted dose must be accounted for patients.


2010 ◽  
Vol 45 (3-6) ◽  
pp. 739-741 ◽  
Author(s):  
Fang-Yuh Hsu ◽  
Ya-Ling Chang ◽  
Mu-Tai Liu ◽  
Sheng-Shien Huang ◽  
Cheng-Ching Yu

2007 ◽  
Vol 52 (22) ◽  
pp. 6779-6780
Author(s):  
T Shimozato ◽  
K Tabushi ◽  
S Kitoh ◽  
Y Shiota ◽  
C Hirayama ◽  
...  

2006 ◽  
Vol 52 (2) ◽  
pp. 515-523 ◽  
Author(s):  
T Shimozato ◽  
K Tabushi ◽  
S Kitoh ◽  
Y Shiota ◽  
C Hirayama ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document